Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2013 (Vol. 33, No. 1)

Glybera’s Story Mirrors that of Gene Therapy

Road to EU Approval Was Paved with Ups and Downs, But the Future Looks Bright

  • Glybera (alipogene tiparvovec) made history on November 2 when the European Union approved its marketing application, making the gene therapy the first to win approval by Western regulators. In many ways, the story of Glybera is the story of AAV and gene therapy itself. The story begins ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.